Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2011 - 2026)

Vanda Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.47 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.47, up 51.03% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47 (up 51.03% YoY), and the FY2025 annual result was 0.38, up 23.86% from the prior year.
• Asset Utilization Ratio came in at 0.47 for Q1 2026 at Vanda Pharmaceuticals, up from 0.4 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.47 in Q1 2026 to a low of 0.27 in Q1 2024.
• The 5-year median for Asset Utilization Ratio is 0.35 (2025), against an average of 0.36.
• Across the five-year window, Asset Utilization Ratio tumbled 32.0% in 2024 and surged 51.03% in 2026, its largest moves.
• Vanda Pharmaceuticals' Asset Utilization Ratio stood at 0.41 in 2022, then slipped by 26.27% to 0.3 in 2023, then climbed by 2.29% to 0.31 in 2024, then increased by 29.79% to 0.4 in 2025, then advanced by 19.09% to 0.47 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.47 (Q1 2026), 0.4 (Q4 2025), and 0.35 (Q3 2025), per Business Quant data.